SEI Investments’s Anavex Life Sciences AVXL Stock Holding History

SEI Investments’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30.1K	Hold	11,611	–	–	﹤0.01%	3252
2026 Q1	$35.6K	Hold	11,611	–	–	﹤0.01%	3195
2025 Q4	$41.3K	Hold	11,611	–	–	﹤0.01%	3089
2025 Q3	$103K	Hold	11,611	–	–	﹤0.01%	2711
2025 Q2	$107K	Sell	11,611 -20	-0.2%	-$171	﹤0.01%	2679
2025 Q1	$99.8K	Buy	+11,631	New	+$110K	﹤0.01%	2592
2021 Q3	–	Sell	-69,645	Closed	-$1.6M	–	2554
2021 Q2	$1.6M	Buy	+69,645	New	+$1.03M	﹤0.01%	1611
2018 Q3	–	Sell	-553	Closed	-$1K	–	2547
2018 Q2	$1K	Buy	+553	New	+$1.54K	﹤0.01%	3427

Other funds holding AVXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

SEI Investments's AVXL Position: Q2 2026 in Review

SEI Investments held its Anavex Life Sciences (AVXL) position steady in Q2 2026 at 11,611 shares worth $30.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3252.

SEI Investments first reported a position in AVXL in Q2 2018 and has held it in 8 quarters since. The position peaked at $1.6M in Q2 2021. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

SEI Investments held 11,611 shares of Anavex Life Sciences worth $30.1K as of Q2 2026.
SEI Investments left its Anavex Life Sciences share count unchanged in Q2 2026.
Anavex Life Sciences made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #3252 holding.
SEI Investments first reported a position in Anavex Life Sciences in Q2 2018 and has held it in 8 quarters since.
SEI Investments's Anavex Life Sciences position peaked at $1.6M in Q2 2021.
179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.